It has been reported that monoallelic deletion of Fbxw7 in different tumor systems, in human and mouse, is a frequent event during cancer progression [15], [29], and that Fbxw7 acts as a haploinsufficient tumor suppressor gene[15], [29]. This evidence concerns the gene FBXW7 and neoplasm.